Research output

  1. Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis

    Research output: Contribution to journalArticleAcademicpeer-review

  2. The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials

    Research output: Contribution to journalArticleAcademicpeer-review

View all (22) »

ID: 5730182